Medical device developer Diality Inc. announced the close of its $24 million Series B2 investment round, according to a press release.
The release noted that dialysis delivery is becoming “decentralized” due to “rising costs and poor outcomes associated with in-center dialysis.” Diality has taken into consideration the cost of delivery for users such as non-specialty nurses, patients and care partners.
“To meet the needs of prescribing physicians and their patients in acute, sub-acute, chronic and home settings, a versatile machine also needs to be capable of